9 completed, 4 unknown, 1 active not recruiting, 1 recruiting. 4 Not applicable, 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Unknown 3, Completed 1 |
| Phase 4 | 2 | Completed 2 |
Follow Compliance: new trials by email Literature Review of Compliance trials Research Report on Compliance
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Flexibility of Tildrakizumab Treatment in Patients With Moderate-to-severe Plaque Psoriasis and High Disease Burden Psoriasis clinical assessment, Assessment of comorbidities, Quality of life evaluation - Psoriasis, Moderate to Severe Psoriasis | Active not recruiting | Clin4all | 150 | 2025-02-18 | 2026-10-28 | |
| Audit of the Revised PACU Centric ERACS Program Compliance with ERACS guideline as described in the current ERACS guidelines from Engelman et al. 2019 - Enhanced Recovery After Surgery, Cardiac Surgical Procedures | Completed | Universitaire Ziekenhuizen KU Leuven | 487 | 2024-01-01 | 2026-05-11 | |
| Compliance and Endometriosis Compliance with medical treatment for endometriosis - Endometriosis | Completed | Hospices Civils de Lyon | 58 | 2022-11-17 | 2024-05-20 | |
| Asthma: Phenotyping Exacerbations 3 Spirometry including peak flow, Fractional Exhaled Nitric Oxide (FeNO), Forced Oscillation Technique (FOT) - Asthma Attack | Unknown | University of Nottingham | 100 | 2022-05-09 | 2022-07-06 | |
| Assessment of Anorectal Function in Patients With Inflammatory Bowel Disease Exposure 1: Visceral hypersensitivity or phenotype suggestive of IBS, Exposure 2: Changes in anorectal motor function or compliance. - Inflammatory Bowel Diseases, Irritable Bowel Syndrome | Recruiting | Region Örebro County | 70 | 2021-09-01 | 2022-02-03 | |
| Clinical Study on Prodovite® VMP35 Supplement on Athletic Performance Clinical Investigation on Enhanced Sports Nutrition and Performance Activities by Prodovite VMP35 Supplement, Broad Spectrum Safety - Athletic Performance | Not applicable | Unknown | Victory Nutrition International, Inc. | 150 | 2021-05-15 | 2021-05-07 |
| Impact of Clinical Pharmacist Interventions in Vitamin K Antagonists Management at One Teaching Hospital in Vietnam Patient education and compliance - Anticoagulation | Not applicable | Unknown | University of Medicine and Pharmacy at Ho Chi Minh City | 800 | 2019-08-01 | 2019-06-26 |
| Endodontic Medications for Irreversible Pulpitis: Articaine or Eugenol? Implementation of a pulp medication in compliance with the dental emergency management protocol: articaïne, Implementation of a pulp medication in compliance with the dental emergency management protocol: eugenol - Pulpitides, Endodontic Inflammation | Completed | University Hospital, Strasbourg, France | 100 | 2018-03-22 | 2020-09-17 | |
| Observatory of Invasive Procedures and Bleeding in Patients Treated With New Oral Anticoagulants complications and compliance with GIHP recommendations - Venous Thromboembolism, Atrial Fibrillation | Completed | University Hospital, Grenoble | 1166 | 2013-06-01 | 2021-10-06 | |
| Meaningful Use of Technology to Improve Health Care Delivery Text Messaging Intervention - Contraceptive Behavior | Not applicable | Completed | Johns Hopkins University | 100 | 2011-01-01 | 2021-03-02 |
| Brief Interventions to Increase HPV Vaccine Acceptance in School-based Health Centers Compliance, Message sidedness - Human Papillomavirus Infection | Not applicable | Unknown | Indiana University | 600 | 2010-09-01 | 2014-02-10 |
| Observational Study On Compliance Of Statin Treatment Of Patients With High Blood Cholesterol Levels Patient Compliance - Dyslipidemia | Completed | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 375 | 2007-10-01 | 2021-02-21 | |
| Study to Improve Quality of Care and Patient Health in the Field of Cardiovascular Risk Factors in General Practice Cardiovascular drugs strategies, Compliance, Exercise - High Risk Hypertensive Patients | Phase 4 | Completed | Collège National des Généralistes Enseignants | 1836 | 2006-11-01 | 2011-11-15 |
| Compliance With Once-Daily Divalproex Extended-Release Tablets (Depakote-ER) Versus Multiple-Daily Dose Valproic Acid Capsules (Depakene) in Epilepsy: Compliance - Epilepsy | Completed | Orlando Health, Inc. | 5 | 2006-07-01 | 2020-03-04 | |
| To Assess Compliance With a Once-daily Regimen of Lamivudine, Efavirenz and Didanosine Compliance - AIDS | Phase 4 | Completed | Bristol-Myers Squibb | 120 | 2004-04-01 | 2011-04-22 |
Patient Compliance (3) · Acquired Immunodeficiency Syndrome (1) · Amenorrhea (1) · Atrial Fibrillation (1) · Contraception Behavior (1) · Diabetes Mellitus, Type 2 (1) · Dyslipidemias (1) · Emergencies (1) · Endometriosis (1) · Epilepsy (1) · Hemorrhage (1) · Hypertension (1) · Inflammatory Bowel Diseases (1) · Irritable Bowel Syndrome (1) · Pain (1)
Bristol-Myers Squibb (1) · Clin4all (1) · Collège National des Généralistes Enseignants (1) · Hospices Civils de Lyon (1) · Indiana University (1) · Johns Hopkins University (1) · Orlando Health, Inc. (1) · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (1) · Region Örebro County (1) · Universitaire Ziekenhuizen KU Leuven (1) · University Hospital, Grenoble (1) · University Hospital, Strasbourg, France (1) · University of Medicine and Pharmacy at Ho Chi Minh City (1) · University of Nottingham (1) · Victory Nutrition International, Inc. (1)
France (5) · United States (4) · Belgium (2) · Sweden (1) · Turkey (Türkiye) (1) · United Kingdom (1) · Vietnam (1)
Danny Feike Hoogma, MD, PhD (1) · Jane Boggs, MD (1) · Maria Trent, MD, MPH (1) · Matthew Martin (1) · Michiel van Nieuwenhoven, assoc prof (1) · Pierre Albaladejo, MD (1) · Trang Dang, PhD (1) · Vaughn I Rickert, PsyD (1)
PMID 24083783, PMID 24492015, PMID 27178974, PMID 31105509, PMID 35785621